Su Hui therapy
Suzhou
About Su Hui therapy
HealiRNA develops infectious disease vaccines, tumor vaccines, cell therapy, and protein replacement. They provide mRNA drug research and development, production, clinical trial design, and data analysis services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $14.5M
- Funding stage: Seed
- Last round: Seed (Mar 2023)
- Website: healrna.com
- Phone: 0512-66033978
Industries & Categories
Alternative Medicine, Biotechnology, Medical
Canonical: https://fsome.com/organization/su-hui-therapy-143226 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.